Johnson & Johnson's single-shot COVID-19 vaccine effective, safe and prevents severe cases: FDA

Johnson & Johnson's single-shot COVID-19 vaccine effective, safe and prevents severe cases: FDA

Jagran English

New Delhi | Jagran News Desk: A review by the US Food and Drug Administration (FDA) of the single-shot coronavirus vaccine developed by the drug maker, Johnson & Johnson, has found it safe and effective against the COVID-19. A briefing document published by the FDA said that the ongoing multi-national Phase 3 randomised, double-blind and placebo-controlled trials of the single-shot vaccine have found that it is about 66% effective at preventing moderate to severe COVID-19, and about 85% effective against the most serious illness.

This could pave way for J&J's single-shot vaccine to become the third vaccine in the US to get emergency use authorisation after Moderna and Pfizer vaccines.

Disclaimer: This is an automatically aggregated article/story by a computer program and has not been created or edited by Newsdig.in.

World COVID19 Meter

141287145

Cases

120129774

Recovered

3017555

Deaths
Last updated: GMT
Advt
Advt
Advt
sitemap Disclaimer
Newsdig.in 2019